Comparing Cognitive Performance of Methadone and Buprenorphine/Naloxone Patients
Author Information
Author(s): Pekka Rapeli, Carola Fabritius, Hannu Alho, Mikko Salaspuro, Kristian Wahlbeck, Hely Kalska
Primary Institution: Helsinki University Central Hospital
Hypothesis
How do cognitive performances of methadone-treated patients compare to buprenorphine/naloxone-treated patients during early opioid substitution treatment?
Conclusion
Methadone-treated patients show more cognitive deficits than buprenorphine/naloxone-treated patients, particularly in attention and verbal memory.
Supporting Evidence
- Methadone patients had slower reaction times compared to buprenorphine/naloxone patients.
- Both patient groups showed deficits in working memory and verbal memory compared to healthy controls.
- Benzodiazepine use was common among participants, which may have affected cognitive performance.
Takeaway
This study found that patients on methadone have more trouble with thinking and remembering than those on buprenorphine/naloxone, especially when they take higher doses.
Methodology
The study compared cognitive performance in 16 methadone patients, 17 buprenorphine/naloxone patients, and 17 healthy controls using various cognitive tests.
Potential Biases
Potential bias due to the common use of benzodiazepines and other psychoactive medications among participants.
Limitations
Cognitive differences may relate to differences in drug tolerance and recent substance abuse history among participants.
Participant Demographics
Participants included 16 methadone patients, 17 buprenorphine/naloxone patients, and 17 healthy controls, aged 18-50.
Statistical Information
P-Value
0.013
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website